ADPT (Adaptive Biotech) Net Profit
Adaptive Biotechnologies (ADPT) net income reflects the impact of high R&D expenses, which is temporarily limiting margins. The value -0.06 represents the current figure for this metric. Growth is driven by the implementation of the clonoSEQ system and strict financial discipline. Business stability is based on a combination of diagnostic services for clinics and support for pharmaceutical research, which minimizes overall regulatory risks.
Analytical breakdowns and data insights for company Adaptive Biotechnologies Corporation (ADPT)
- price and consensus price forecast:
- business market valuation indicators:
- book capitalization data:
- debt and solvency information:
Total Debt to Equity Ratio Adaptive Biotechnologies|ADPT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Adaptive Biotech|ADPT - Company Total Debt|Debts to Book Capitalization Adaptive Biotechnologies Inc.|ADPT - Company Long-Term Debt|Company Short-Term Indebtedness Adaptive Biotechnologies|Immediate Liquidity adaptivebiotech.com
- net income and valuation multiples indicators:
Summary company analysis:Adaptive Biotechnologies
To objectively value an asset, one must compare its market value with the business's actual ability to generate cash flow. By analyzing the total profit of Adaptive Biotechnologies (ADPT), an investor can see the bottom-line financial result after all expenses, which is critical for Adaptive Biotechnologies during its management transformation and the search for commercial returns from new partnerships in the field of immunomedicine.
Main competitors
Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|celldex.com (CLDX) - Net Income|Aurinia Pharmaceuticals Inc. (AUPH) - Company Net Income|Net Income BioCryst Pharmaceuticals, Inc.|Net Income VERA|Net Profit Dianthus Corp|Company Net Income Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Company Profit|Net Profit TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Company Net Income|Pharming - Net Profit|NKTR - Net Profit|UPB: Net Profit|Company Profit ZBIO|IMNM (Immunome) - Net Profit|Net Profit Gossamer Bio Inc|Company Net Income KalVista Pharmaceuticals Inc (KALV)|SEPN: Profit After Tax|Pieris Pharmaceuticals - Net Income|Profit After Payment of Taxes SVRA (savarapharma.com)|Rigel Pharmaceuticals, Inc. - Net Profit|Net Financial Result AnaptysBio Inc ANAB|ATXS (Astria Pharma) - Net Income|ENGN (enGene Corp) - Company Net Income|RAPT (RAPT Therapeutics, Inc.) - Net Profit|Company Net Income Aerovate JBIO|Net Income ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Final Profit|Net Profit TLSA (Tiziana Life Sciences PLC)|Cabaletta Bio Inc - Company Net Income|Ventyx Biosciences - Net Profit|Net Financial Result theratech.com THTX|Avalo Therapeutics (AVTX) - Company Net Income|Company Net Income Eledon Pharmaceuticals Inc. (ELDN)|Net Income AGEN|CLYM (Climb Bio, Inc) - Profit After Payment of Taxes|Net Profit ZURA|ATYR - Company Net Income|Net Profit ADAG (Adagene Inc.)|IMA - Net Income|Shattuck Therapeutics - Net Profit|Final Profit EQ (Equillium, Inc.)|connectbiopharm.com (CNTB) - Company Net Income|Company Profit IMUX|Company Net Income Atara Biotherapeutics, Inc.|Company Net Income InflaRx GmbH IFRX|Company Net Income X4 Pharma (XFOR)|Company Net Income ACET (adicetbio.com)|Company Net Income Celularity CELU|inmunebio.com (INMB) - Company Net Income|Barinthus Biotherapeutics plc - Net Profit|Annual Net Income Kezar Life Sciences Inc. (KZR)|SABS: Net Profit|AKTX - Net Financial Result|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Company Net Income Q32 Bio Corp QTTB|Company Net Income GeoVax (GOVX)|Net Financial Result Edesa Biotech Inc|Net Profit IBIO (iBio Corp)|Net Profit Carisma Therapeutics Inc CARM|XTL Biopharmaceuticals - Net Profit|BOLT (Bolt Biotherapeutics) - Company Profit|hcwbiologics.com (HCWB) - Company Net Income|Profit After Tax APVO (Aptevo Therapeutics Inc.)|Net Income AIM|ADTX (Aditxt Corp) - Profit After Payment of Taxes|Company Net Income GRI Bio, Inc. (GRI)|XRTX: Profit After Tax|Net Profit HIND (Vyome Holdings)|Final Profit REVB|Indaptus - Net Profit|SCNI - Net Profit|calcimedica.com (CALI) - Company Net Income|Affimed N.V. - Final Profit|Company Net Income Allakos Inc|Net Income HOOKIPA (HOOK)|Net Profit IGMS|Net Profit iTeos Pharma (ITOS)|Ocean Biomedical, Inc. - Net Income|Final Profit TCBP|Third Harmonic Bio, Inc. - Net Profit